Effect of azithromycin plus rifampin versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis
- PMID: 10348778
- PMCID: PMC89304
- DOI: 10.1128/AAC.43.6.1491
Effect of azithromycin plus rifampin versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis
Abstract
Azithromycin, doxycycline, and rifampin, alone or in combination, were tested in vitro against Chlamydia pneumoniae AR-39. The combination of azithromycin plus rifampin showed the strongest activity and produced higher rates of eradication of C. pneumoniae from lung tissues than azithromycin alone in experimental mouse pneumonitis.
Similar articles
-
Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice.Antimicrob Agents Chemother. 2000 Jun;44(6):1761-4. doi: 10.1128/AAC.44.6.1761-1764.2000. Antimicrob Agents Chemother. 2000. PMID: 10817751 Free PMC article.
-
Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis.Antimicrob Agents Chemother. 1995 Jan;39(1):45-9. doi: 10.1128/AAC.39.1.45. Antimicrob Agents Chemother. 1995. PMID: 7695327 Free PMC article.
-
Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia.Antimicrob Agents Chemother. 1998 Jan;42(1):194-6. doi: 10.1128/AAC.42.1.194. Antimicrob Agents Chemother. 1998. PMID: 9449287 Free PMC article.
-
Advances in the management of Chlamydia pneumoniae infections.Expert Rev Anti Infect Ther. 2003 Oct;1(3):493-503. doi: 10.1586/14787210.1.3.493. Expert Rev Anti Infect Ther. 2003. PMID: 15482145 Review.
-
Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease.Am Heart J. 1999 Nov;138(5 Pt 2):S539-41. doi: 10.1016/s0002-8703(99)70296-6. Am Heart J. 1999. PMID: 10539869 Review. No abstract available.
Cited by
-
Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia.Antimicrob Agents Chemother. 2005 Sep;49(9):3970-3. doi: 10.1128/AAC.49.9.3970-3973.2005. Antimicrob Agents Chemother. 2005. PMID: 16127085 Free PMC article.
-
A platform supporting generation and isolation of random transposon mutants in Chlamydia trachomatis.J Bacteriol. 2025 Mar 20;207(3):e0050024. doi: 10.1128/jb.00500-24. Epub 2025 Feb 14. J Bacteriol. 2025. PMID: 39950807 Free PMC article.
-
Causality of Chlamydiae in Arthritis and Spondyloarthritis: a Plea for Increased Translational Research.Curr Rheumatol Rep. 2016 Feb;18(2):9. doi: 10.1007/s11926-015-0559-3. Curr Rheumatol Rep. 2016. PMID: 26769308 Review.
-
Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles.Biomaterials. 2011 Sep;32(27):6606-13. doi: 10.1016/j.biomaterials.2011.05.038. Epub 2011 Jun 8. Biomaterials. 2011. PMID: 21652065 Free PMC article.
-
Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice.Antimicrob Agents Chemother. 2000 Jun;44(6):1761-4. doi: 10.1128/AAC.44.6.1761-1764.2000. Antimicrob Agents Chemother. 2000. PMID: 10817751 Free PMC article.
References
-
- Bowie W R, Lee C K, Alexander E R. Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis. J Infect Dis. 1978;138:655–659. - PubMed
-
- Danesk J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430–436. - PubMed
-
- Furesz S. Chemical and biological properties of rifampicin. Antibiot Chemother (Basel) 1970;16:316–351. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials